Experimental Ebola Vaccine Trial

NCT00072605 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

NIH

Sponsor class

Conditions

Hemorrhagic Fever, Ebola
Healthy

Interventions

DRUG: VRC-EBODNA012-00-VP

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)